Skip to content

Establishment and Application of an Integrated Cloud Platform for Elderly Motor and Cognitive Impairment: Early Warning, Assessment, Intervention and Management

Establishment and Application of an Integrated Cloud Platform for Elderly Motor and Cognitive Impairment: Early Warning, Assessment, Intervention and Management

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111236
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor and Cognitive Impairment

Interventions

Intelligent Rehabilitation Group:Participants receive individualized rehabilitation protocols generated by the intelligent cloud platform, with a treatment duration of 2 weeks, administered once daily
Conventional Rehabilitation Group:Participants receive conventional rehabilitation protocols, with a treatment duration of 2 weeks, administered once daily, five times per week.

Sponsors

The Third Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age between 60 and 85 years; 2. Presence of one or more motor or cognitive impairments, including restricted joint mobility, decreased muscle strength, abnormal muscle tone, reduced muscle endurance, upper limb incoordination, fine motor deficits, balance dysfunction, gait abnormalities, tremor, cardiopulmonary dysfunction, memory impairment, visuospatial deficits, executive dysfunction, calculation difficulty, attention deficit, disorientation, speech impairment, or sensory-perceptual disturbances; 3. Willingness to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe cognitive impairment who are wholly incapable of comprehending the trial content and providing informed consent; 2. Individuals with unstable medical conditions such as active bleeding, severe infection, serious cardiopulmonary disease, multiple organ failure, brain tumours, or severe psychiatric disorders; 3. Individuals with new-onset fractures or open wounds; 4. Individuals with severe visual or hearing impairments, such as colour blindness or deafness; 5. Individuals currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Motor function behavioral assessment (including the 6-minute walk test, handgrip strength test, and manual muscle testing).;Cognitive function behavioral assessment (including the Mini-Mental State Examination and the Montreal Cognitive Assessment).;Activities of daily living assessment (including the IADL scale, BADL scale, and FIM scale).;Multimodal neurophysiological assessment (including resting-state electroencephalography, event-related potentials, and surface electromyography).;

Countries

China

Contacts

Public ContactZheng Haiqing

The Third Affiliated Hospital of Sun Yat-Sen University

zhenghaiqing0909@aliyun.com+86 136 6234 3899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026